Rap2b, a novel p53 target, regulates p53-mediated pro-survival function

Cell Cycle

Volumn 12, Issue 8, 2013, Pages 1279-1291

  Zhang, Xinyue ^a   He, Yunlong ^a   Lee, Kyoung Hwa ^b   Dubois, Wendy ^a   Li, Ziqing ^a   Wu, Xiaolin ^c   Kovalchuk, Alexander ^d   Zhang, Weimin ^e   Huang, Jing ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Seoul National University   (South Korea)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chromatin; Epigenetics; Gene regulation; P53

Indexed keywords

PROTEIN; PROTEIN P53; RAP2B PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

AMINO ACID SEQUENCE; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL FATE; CELL PROLIFERATION; CELL STRAIN HCT116; CELL SURVIVAL; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; DNA SEQUENCE; GENE EXPRESSION; MOUSE; NONHUMAN; ONCOGENE; PHYLOGENY; PROMOTER REGION; RAT; RNA INTERFERENCE; SITE DIRECTED MUTAGENESIS; STRESS; TRANSCRIPTION INITIATION SITE; UPREGULATION;

EID: 84876245568     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.24364     Document Type: Article

References (56)

1. Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137:413-31; PMID:19410540; http://dx.doi.org/10.1016/j.cell. 2009.04.037
2. Kruse JP, Gu W. Modes of p53 regulation. Cell 2009; 137:609-22; PMID:19450511; http://dx.doi.org/10.1016/j.cell.2009.04.050
3. Rozan LM, El-Deiry WS. p53 downstream target genes and tumor suppression: A classical view in evolution. Cell Death Differ 2007; 14:3-9; PMID:17068503; http://dx.doi.org/10.1038/sj.cdd.4402058
4. Zhang X, Huang J. Integrative genome-wide approaches in embryonic stem cell research. Integr Biol (Camb) 2010; 2:510-6; PMID:20852801; http://dx.doi.org/10.1039/c0ib00068j
5. Schlereth K, Charles JP, Bretz AC, Stiewe T. Life or death: P53-induced apoptosis requires DNA binding cooperativity. Cell Cycle 2010; 9:4068-76; PMID:20948308; http://dx.doi.org/10.4161/cc.9.20.13595
6. Helton ES, Chen X. p53 modulation of the DNA damage response. J Cell Biochem 2007; 100:883-96; PMID:17031865; http://dx.doi.org/10.1002/jcb.21091
7. Aylon Y, Oren M. Living with p53, dying of p53. Cell 2007; 130:597-600; PMID:17719538; http://dx.doi.org/10.1016/j.cell.2007.08.005
8. Jänicke RU, Sohn D, Schulze-Osthoff K. The dark side of a tumor suppressor: Anti-apoptotic p53. Cell Death Differ 2008; 15:959-76; PMID:18356920; http://dx.doi.org/10.1038/cdd.2008.33
9. Tang Y, Luo J, Zhang W, Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 2006; 24:827-39; PMID:17189186; http://dx.doi.org/10.1016/j.molcel.2006.11.021
10. Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS, et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 2006; 24:841-51; PMID:17189187; http://dx.doi.org/10.1016/j.molcel.2006.11. 026
11. Das S, Raj L, Zhao B, Kimura Y, Bernstein A, Aaronson SA, et al. Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell 2007; 130:624-37; PMID:17719541; http://dx.doi.org/10. 1016/j.cell.2007.06.013
12. Tanaka T, Ohkubo S, Tatsuno I, Prives C. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell 2007; 130:638-50; PMID:17719542; http://dx.doi.org/10.1016/j.cell.2007.08.001
13. Wu WS, Heinrichs S, Xu D, Garrison SP, Zambetti GP, Adams JM, et al. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005; 123:641-53; PMID:16286009; http://dx.doi.org/10.1016/j.cell. 2005.09.029
14. Caratozzolo MF, Micale L, Turturo MG, Cornacchia S, Fusco C, Marzano F, et al. TRIM8 modulates p53 activity to dictate cell cycle arrest. Cell Cycle 2012; 11:511-23; PMID:22262183; http://dx.doi.org/10.4161/cc.11.3.19008
15. Xu Y, Chen X. Glyoxalase II, a detoxifying enzyme of glycolysis byproduct methylglyoxal and a target of p63 and p73, is a pro-survival factor of the p53 family. J Biol Chem 2006; 281:26702-13; PMID:16831876; http://dx.doi.org/10. 1074/jbc.M604758200
16. Leontieva OV, Gudkov AV, Blagosklonny MV. Weak p53 permits senescence during cell cycle arrest. Cell Cycle 2010; 9:4323-7; PMID:21051933; http://dx.doi.org/10.4161/cc.9.21.13584
17. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358:80-3; PMID:1614537; http://dx.doi.org/10.1038/358080a0
18. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 1993; 53:2736-9; PMID:8504413
19. Pei D, Zhang Y, Zheng J. Regulation of p53: A collaboration between Mdm2 and Mdmx. Oncotarget 2012; 3:228-35; PMID:22410433
20. Viale A, De Franco F, Orleth A, Cambiaghi V, Giuliani V, Bossi D, et al. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 2009; 457:51-6; PMID:19122635; http://dx.doi.org/10.1038/ nature07618
21. Gasparini G, Longo R, Sarmiento R, Morabito A. Inhibitors of cyclo-oxygenase 2: A new class of anticancer agents? Lancet Oncol 2003; 4:605-15; PMID:14554238; http://dx.doi.org/10.1016/S1470-2045(03)01220-8
22. Vousden KH, Lu X. Live or let die: The cell's response to p53. Nat Rev Cancer 2002; 2:594-604; PMID:12154352; http://dx.doi.org/10.1038/nrc864
23. Li M, He Y, Feng X, Huang J. Genome-wide studies of the transcriptional regulation by p53. Biochim Biophys Acta 2012; 1819:684-7; PMID:22348878; http://dx.doi.org/10.1016/j.bbagrm.2012.02.002
24. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9:402-12; PMID:18431400; http://dx.doi.org/10.1038/nrm2395
25. Li M, He Y, Dubois W, Wu X, Shi J, Huang J. Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol Cell 2012; 46:30-42; PMID:22387025; http://dx.doi.org/10.1016/j.molcel. 2012.01.020
26. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006; 124:207-19; PMID:16413492; http://dx.doi.org/10.1016/j.cell.2005.10.043
27. Smeenk L, van Heeringen SJ, Koeppel M, van Driel MA, Bartels SJ, Akkers RC, et al. Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 2008; 36:3639-54; PMID:18474530; http://dx.doi.org/10.1093/nar/gkn232
28. Lee KH, Li M, Michalowski AM, Zhang X, Liao H, Chen L, et al. A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc Natl Acad Sci USA 2010; 107:69-74; PMID:20018659; http://dx.doi.org/10.1073/pnas.0909734107
29. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010; 142:409-19; PMID:20673990; http://dx.doi.org/10.1016/j.cell.2010.06.040
30. Choi YJ, Lin CP, Ho JJ, He X, Okada N, Bu P, et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 2011; 13:1353-60; PMID:22020437; http://dx.doi.org/10.1038/ncb2366
31. Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell 2006; 10:105-16; PMID:16399082; http://dx.doi.org/10.1016/j. devcel.2005.10.017
32. Brosh R, Sarig R, Natan EB, Molchadsky A, Madar S, Bornstein C, et al. p53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss. FEBS Lett 2010; 584:2473-7; PMID:20434500; http://dx.doi.org/10.1016/j.febslet. 2010.04.058
33. Rouault JP, Falette N, Guéhenneux F, Guillot C, Rimokh R, Wang Q, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 1996; 14:482-6; PMID:8944033; http://dx.doi.org/10.1038/ng1296-482
34. Barak Y, Juven T, Haffner R, Oren M. mdm2 expression is induced by wild type p53 activity. EMBO J 1993; 12:461-8; PMID:8440237
35. Yang G, Zhang G, Pittelkow MR, Ramoni M, Tsao H. Expression profiling of UVB response in melanocytes identifies a set of p53-target genes. J Invest Dermatol 2006; 126:2490-506; PMID:16888633; http://dx.doi.org/10.1038/sj.jid. 5700470
36. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994; 54:1169-74; PMID:8118801
37. Wu GS, Burns TF, McDonald ER 3rd, Jiang W, Meng R, Krantz ID, et al. KILLER/DR5 is a DNA damageinducible p53-regulated death receptor gene. Nat Genet 1997; 17:141-3; PMID:9326928; http://dx.doi.org/10.1038/ng1097-141
38. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7:683-94; PMID:11463392; http://dx.doi.org/10.1016/S1097- 2765(01)00214-3
39. Catalano A, Rodilossi S, Caprari P, Coppola V, Procopio A. 5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation. EMBO J 2005; 24:170-9; PMID:15616590; http://dx.doi.org/10.1038/sj. emboj.7600502
40. Hong Y, Stambrook PJ. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc Natl Acad Sci USA 2004; 101:14443-8; PMID:15452351; http://dx.doi.org/10.1073/pnas. 0401346101
41. Liu G, Chen X. Regulation of the p53 transcriptional activity. J Cell Biochem 2006; 97:448-58; PMID:16288459; http://dx.doi.org/10.1002/jcb.20700
42. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004; 303:844-8; PMID:14704432; http://dx.doi.org/10.1126/science. 1092472
43. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1992; 1:45-9; PMID:1301998; http://dx.doi.org/10.1038/ng0492-45
44. Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 2004; 119:847-60; PMID:15607980; http://dx.doi.org/10.1016/j.cell.2004.11.004
45. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Murcia JM. Importance of poly(ADPribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 1998; 273:33533-9; PMID:9837934; http://dx.doi.org/10.1074/jbc.273.50.33533
46. Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, et al. P53-mediated induction of Cox-2 counteracts p53-or genotoxic stress-induced apoptosis. EMBO J 2002; 21:5635-44; PMID:12411481; http://dx.doi.org/10.1093/ emboj/cdf591
47. Koeppel M, van Heeringen SJ, Smeenk L, Navis AC, Janssen-Megens EM, Lohrum M. The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response. Nucleic Acids Res 2009; 37:322-35; PMID:19042971; http://dx.doi.org/10.1093/nar/gkn940
48. Seoane J, Le HV, Massagué J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 2002; 419:729-34; PMID:12384701; http://dx.doi.org/10.1038/nature01119
49. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009; 137:835-48; PMID:19490893; http://dx.doi.org/10.1016/j.cell.2009.05.006
50. Laptenko O, Prives C. Transcriptional regulation by p53: One protein, many possibilities. Cell Death Differ 2006; 13:951-61; PMID:16575405; http://dx.doi.org/10.1038/sj.cdd.4401916
51. Wilkinson DS, Tsai WW, Schumacher MA, Barton MC. Chromatin-bound p53 anchors activated Smads and the mSin3A corepressor to confer transforminggrowth-factor-beta-mediated transcription repression. Mol Cell Biol 2008; 28:1988-98; PMID:18212064; http://dx.doi.org/10.1128/MCB.01442-07
52. Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ, et al. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 1999; 13:2490-501; PMID:10521394; http://dx.doi.org/10.1101/gad.13.19.2490
53. Tsai WW, Nguyen TT, Shi Y, Barton MC. p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol Cell Biol 2008; 28:5139-46; PMID:18573881; http://dx.doi.org/10.1128/MCB.00287-08
54. Carvajal LA, Hamard PJ, Tonnessen C, Manfredi JJ. E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression. Genes Dev 2012; 26:1533-45; PMID:22802528; http://dx.doi.org/10. 1101/gad.184911.111
55. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80:293-9; PMID:7834749; http://dx.doi.org/10.1016/0092-8674(95)90412-3
56. Riccardi C, Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 2006; 1:1458-61; PMID:17406435; http://dx.doi.org/10.1038/nprot.2006.238